Medicinal Chemistry Lab
Inicio BotoneraFin Botonera
Publications
Use menu on the left to navigate through Lab publications, sorted by year. Follow the link to access each one of them.

Publications 2020 - Current


Competitive upconversion-linked immunoassay using peptide mimetics for the detection of the mycotoxin zearalenone

Authors: R. Peltomaa, Z. Farka, M.J. Mickert, J.C. Brandmeier, M. Pastucha, A. Hlavá?ek, M. Martínez-Orts, Á. Canales, P. Skládal, E. Benito-Peña, M.C. Moreno-Bondi, H.H. Gorris
Publication: Biosens. Bioelectron.
Year: 2020 Volume: 170 Pages: 112683 to 112691
[Check out this article at Pubmed] PublMed


Efficient chemoenzymatic synthesis of N-glycans with a beta-1,4-galactosylated bisecting GlcNAc motif

Authors: M. Weiss, D. Ott, T. Karagiannis, M. Weishaupt, M. Niemietz, S. Eller, M. Lott, M. Martínez-Orts, Á. Canales, N. Razi, J.C. Paulson, C. Unverzagt
Publication: ChemBioChem
Year: 2020 Volume: 21 Pages: 3212 to 3215
[Check out this article at Pubmed] PublMed


Glucose metabolism links astroglial mitochondria to cannabinoid effects

Authors: D. Jimenez-Blasco, A. Busquets-Garcia, E. Hebert-Chatelain, R. Serrat, C. Vicente-Gutierrez, C. Ioannidou, P. Gómez-Sotres, I. Lopez-Fabuel, M. Resch-Beusher, E. Resel, D. Arnouil, D. Saraswat, M. Varilh, A. Cannich, F. Julio-Kalajzic, I. Bonilla-Del Río, A. Almeida, N. Puente, S. Achicallende, M.L. López-Rodríguez, C. Jollé, N. Déglon, L. Pellerin, C. Josephine, G. Bonvento, A. Panatier, B. Lutz, P.-V. Piazza, M. Guzmán, L. Bellocchio, A.-K. Bouzier-Sore, P. Grandes, J.P. Bolaños, G. Marsicano
Publication: Nature
Year: 2020 Volume: 583 Pages: 603 to 608
[Check out this article at Pubmed] PublMed


A novel agonist of the type 1 lysophosphatidic acid receptor (LPA1), UCM-05194, shows efficacy in neuropathic pain amelioration

Authors: I. Gonzalez-Gil, D. Zian, H. Vázquez-Villa, G. Hernandez-Torres, R.F. Martinez, N. Khiar-Fernandez, R. Rivera, Y. Kihara, I. Devesa, S. Mathivanan, C. Rosell del Valle, E. Zambrana-Infantes, M. Puigdomenech, G. Cincilla, M. Sanchez-Martinez, F. Rodriguez de Fonseca, A. Ferrer-Montiel, J. Chun, R. Lopez-Vales, M.L. López-Rodríguez, S. Ortega-Gutierrez
Publication: J. Med. Chem.
Year: 2020 Volume: 63 Pages: 2372 to 2390
[Check out this article at Pubmed] PublMed


Serum endocannabinoid levels in suicide attempters: A pilot study

Authors: J. Herranz-Herrer, E. Gil-Benito, T. Ponte-López, S. Ortega-Gutiérrez, J. Macicior, S. Rosado-Garcia, A.J. Sánchez-López, H. Blasco-Fontecilla
Publication: Eur. Neuropsychopharmacol.
Year: 2020 Volume: 40 Pages: 52 to 60
[Check out this article at Pubmed] PublMed


Membrane disruption, but not metabolic rewiring, is the key mechanism of anticancer action of FASN inhibitors: a multi-omics analysis in ovarian cancer

Authors: T.W. Grunt, A. Slany, M. Semkova, R. Colomer, M.L. López-Rodríguez, M. Wuczkowski, R. Wagner, C. Gerner, G. Stübiger
Publication: Sci. Rep.
Year: 2020 Volume: 10 Pages: 14877 to 14887
[Check out this article at Pubmed] PublMed


The cannabinoid WIN55212-2 restores rhinovirus-induced epithelial barrier disruption

Authors: A. Angelina, M. Martín-Fontecha, B. Rückert, P. Wawrzyniak, M. Pérez-Diego, J. López-Abente, M. Akdis, C.A. Akdis, O. Palomares
Publication: Allergy
Year: 2021 Volume: 76 Pages: 1900 to 1902
[Check out this article at Pubmed] PublMed


Chemistry for the identification of therapeutic targets: Recent advances and future directions

Authors: N. Khiar-Fernandez, J. Macicior, B. Marcos-Ramiro, S. Ortega-Gutierrez
Publication: Eur. J. Org. Chem.
Year: 2021 Volume: 2021 Pages: 1307 to 1320
[Check out this article at Pubmed] PublMed


The pharmacological or genetic blockade of endogenous de novo fatty acid synthesis does not increase the uptake of exogenous lipids in ovarian cancer cells

Authors: T.W. Grunt, L. Lemberger, R. Colomer, M.L. López-Rodríguez, R. Wagner
Publication: Front. Oncol. doi: 10.3389/fonc.2021.610885
Year: 2021 Volume: 11 Pages: 610885 to 610895
[Check out this article at Pubmed] PublMed


Targeting the FtsZ allosteric binding site with a novel fluorescence polarization screen, cytological and structural approaches for antibacterial discovery

Authors: S. Huecas, L. Araújo-Bazán, F.M. Ruiz, L.B. Ruiz-Ávila, R.F. Martínez, A. Escobar-Peña, M. Artola, H. Vázquez-Villa, M. Martín-Fontecha, C. Fernández-Tornero, M.L. López-Rodríguez, J.M. Andreu
Publication: J. Med. Chem.
Year: 2021 Volume: 64 Pages: 5730 to 5745
[Check out this article at Pubmed] PublMed


Small-molecule therapeutic perspectives for the treatment of progeria

Authors: J. Macicior, B. Marcos-Ramiro, S. Ortega-Gutiérrez
Publication: Int. J. Mol. Sci.
Year: 2021 Volume: 22 Pages: 7190 to 7200
[Check out this article at Pubmed] PublMed


Isoprenylcysteine carboxylmethyltransferase-based therapy for Hutchinson–Gilford progeria syndrome

Authors: B. Marcos-Ramiro, A. Gil-Ordóñez, N.I. Marín-Ramos, F. J. Ortega-Nogales, M. Balabasquer, P. Gonzalo, N. Khiar-Fernández, L. Rolas, A. Barkaway, S. Nourshargh, V. Andrés, M. Martín-Fontecha, M.L. López-Rodríguez, S. Ortega-Gutiérrez
Publication: ACS Cent. Sci.
Year: 2021 Volume: 8 Pages: 1300 to 1310
[Check out this article at Pubmed] PublMed


The search for antibacterial inhibitors targeting cell division protein FtsZ at its nucleotide and allosteric binding sites

Authors: J.M. Andreu, S. Huecas, L. Araújo-Bazán, H. Vázquez-Villa, M. Martín-Fontecha
Publication: Biomedicines
Year: 2022 Volume: 10 Pages: 1825 to 1837
[Check out this article at Pubmed] PublMed


Discovery of V-0219: A small-molecule positive allosteric modulator of the glucagon-like peptide-1 receptor toward oral treatment for “Diabesity”

Authors: J.M. Decara, H. Vázquez-Villa, J. Brea, M. Alonso, R.K. Srivastava, L. Orio, F. Alén, J. Suárez, E. Baixeras, J. García-Cárceles, A. Escobar-Peña, B. Lutz, R. Rodríguez, E. Codesido, F.J. Garcia-Ladona, T.A. Bennett, J.A. Ballesteros, J. Cruces, M.I. Loza, B. Benhamú, F. Rodríguez de Fonseca, M.L. López-Rodríguez
Publication: J. Med. Chem.
Year: 2022 Volume: 65 Pages: 5449 to 5461
[Check out this article at Pubmed] PublMed


New trends in aging drug discovery

Authors: B. Benhamú, M. Martín-Fontecha, H. Vázquez-Villa, M.L. López-Rodríguez, S. Ortega-Gutiérrez
Publication: Biomedicines
Year: 2022 Volume: 10 Pages: 2006 to 2039
[Check out this article at Pubmed] PublMed


Novel antagonist of the type 2 lysophosphatidic acid receptor (LPA2), UCM-14216, ameliorates spinal cord injury in mice

Authors: N. Khiar-Fernández, D. Zian, H. Vázquez-Villa, R.F. Martínez, A. Escobar-Peña, R. Foronda-Sainz, M. Ray, M. Puigdomenech-Poch, G. Cincilla, M. Sánchez-Martínez, Y. Kihara, J. Chun, R. López-Vales, M.L. López-Rodríguez, S. Ortega-Gutiérrez
Publication: J. Med. Chem. doi: 10.1021/acs.jmedchem.2c00046
Year: 2022 Volume: 0 Pages: 0 to 0
[Check out this article at Pubmed] PublMed


2-(Fluoromethoxy)-4'-(S-methanesulfonimidoyl)-1,1?-biphenyl (UCM-1306), an orally bioavailable positive allosteric modulator of the human dopamine D1 receptor for Parkinson’s disease

Authors: J. García-Cárceles, H. Vázquez-Villa, J. Brea, D. Ladron de Guevara-Miranda, G. Cincilla, M. Sánchez-Martínez, A. Sánchez-Merino, S. Algar, M.T. de los Frailes, R.S. Roberts, J.A. Ballesteros, F. Rodríguez de Fonseca, B. Benhamú, M.I. Loza, M.L. López-Rodríguez
Publication: J. Med. Chem. doi: 10.1021/acs.jmedchem.2c00949
Year: 2022 Volume: 0 Pages: 0 to 0
[Check out this article at Pubmed] PublMed



Top
Fin sección
All rights reserved
Copyright Medicinal Chemistry Lab - Universidad Complutense de Madrid / 2015